Notably, key genes for CRC progression like the Tumor protein p53 (TP53) (60% versus 20%) and the Adenomatous Polyposis Coli (APC) (81% versus 51%) were significantly highly mutated in non-hypermutated tumors [42]. Here, TP53 is linked to polyposis.